Access to anti-retroviral drugs, male in Malawi

Malawi: Access to anti-retroviral drugs, male was 90.0% in 2024. ◆ Volatile

Latest (2024)
90.0%
Change on year
up 1.1%
World rank
13th
of 141 countries
All-time high
90.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Malawi, 2000–2024

0204060801002000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 1 %2005: 3 %2006: 7 %2007: 11 %2008: 18 %2009: 23 %2010: 29 %2011: 35 %2012: 41 %2013: 47 %2014: 52 %2015: 57 %2016: 64 %2017: 72 %2018: 78 %2019: 79 %2020: 83 %2021: 85 %2022: 87 %2023: 89 %2024: 90 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Malawi is 90.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 1.1% on the previous year and up 73.1% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Malawi peaked at 90.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Malawi 13th out of 141 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Malawi, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Malawi, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 3.0% +200.0%
2006 7.0% +133.3%
2007 11.0% +57.1%
2008 18.0% +63.6%
2009 23.0% +27.8%
2010 29.0% +26.1%
2011 35.0% +20.7%
2012 41.0% +17.1%
2013 47.0% +14.6%
2014 52.0% +10.6%
2015 57.0% +9.6%
2016 64.0% +12.3%
2017 72.0% +12.5%
2018 78.0% +8.3%
2019 79.0% +1.3%
2020 83.0% +5.1%
2021 85.0% +2.4%
2022 87.0% +2.4%
2023 89.0% +2.3%
2024 90.0% +1.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.3% 0.0% 23.0% 10
2010s 55.4% 29.0% 79.0% 10
2020s 86.8% 83.0% 90.0% 5

Countries ranked near Malawi

  1. 11 Botswana 92.0% compare
  2. 12 Spain 91.0% compare
  3. 13 Burundi 90.0% compare
  4. 13 Namibia 90.0% compare
  5. 13 Switzerland 90.0% compare

See the full ranking of 160 places →

More gender data for Malawi

All data for Malawi →

Frequently asked questions

What is access to anti-retroviral drugs, male in Malawi?
Access to anti-retroviral drugs, male in Malawi was 90.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Malawi?
The highest recorded value was 90.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Malawi?
The lowest recorded value was 0.0% in 2000.
How does Malawi rank for access to anti-retroviral drugs, male?
Malawi ranks 13th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Malawi?
Over the last ten years it is up 73.1%. The long-run trend across the full record is volatile.
Where does this Malawi data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Malawi. Statizoid, drawing on UNAIDS estimates. Retrieved 07 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/malawi/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/malawi/">Access to anti-retroviral drugs, male in Malawi</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.